Prediabetes: Forget Lifestyle and Just Prescribe Drugs?
8.4 هزار بار بازدید -
5 سال پیش
-
A new study suggests that
A new study suggests that maybe we should be treating patients with prediabetes with not just one but three antidiabetes drugs.
In the STOP DIABETES trial,[1] 81 prediabetes patients determined to be at high risk for progression to diabetes were treated with low-dose metformin, pioglitazone, and a GLP-1 receptor agonist. A larger group of 141 patients determined to be at intermediate risk were treated with metformin and pioglitazone. Both groups also received lifestyle therapy, as did patients who refused pharmacotherapy.
In the STOP DIABETES trial,[1] 81 prediabetes patients determined to be at high risk for progression to diabetes were treated with low-dose metformin, pioglitazone, and a GLP-1 receptor agonist. A larger group of 141 patients determined to be at intermediate risk were treated with metformin and pioglitazone. Both groups also received lifestyle therapy, as did patients who refused pharmacotherapy.
5 سال پیش
در تاریخ 1398/04/13 منتشر شده
است.
8,476
بـار بازدید شده